Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of IDEX Co. (NYSE:IEX - Free Report) by 12.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 56,718 shares of the industrial products company's stock after acquiring an additional 6,096 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned 0.07% of IDEX worth $12,166,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Boston Trust Walden Corp increased its stake in IDEX by 3.3% in the second quarter. Boston Trust Walden Corp now owns 223,892 shares of the industrial products company's stock valued at $45,047,000 after acquiring an additional 7,222 shares during the last quarter. D. E. Shaw & Co. Inc. boosted its holdings in shares of IDEX by 247.0% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 198,170 shares of the industrial products company's stock valued at $39,872,000 after purchasing an additional 141,064 shares in the last quarter. Qsemble Capital Management LP bought a new position in shares of IDEX in the 2nd quarter valued at $3,627,000. Marshall Wace LLP raised its holdings in shares of IDEX by 162.1% during the 2nd quarter. Marshall Wace LLP now owns 101,558 shares of the industrial products company's stock worth $20,433,000 after buying an additional 62,803 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its position in shares of IDEX by 2.7% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 168,023 shares of the industrial products company's stock worth $36,041,000 after buying an additional 4,465 shares during the last quarter. 97.96% of the stock is currently owned by institutional investors.
IDEX Trading Down 0.2 %
Shares of IDEX stock traded down $0.47 during trading on Friday, hitting $230.63. The company's stock had a trading volume of 268,772 shares, compared to its average volume of 645,143. The stock has a market cap of $17.46 billion, a price-to-earnings ratio of 35.70, a price-to-earnings-growth ratio of 2.44 and a beta of 0.96. IDEX Co. has a 52 week low of $189.51 and a 52 week high of $246.36. The stock has a 50-day moving average price of $217.66 and a two-hundred day moving average price of $208.15. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.97 and a quick ratio of 2.11.
IDEX (NYSE:IEX - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The industrial products company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.01. The firm had revenue of $798.20 million for the quarter, compared to analyst estimates of $793.05 million. IDEX had a return on equity of 15.92% and a net margin of 15.35%. The business's revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.12 EPS. Equities research analysts anticipate that IDEX Co. will post 7.89 EPS for the current fiscal year.
IDEX Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, January 17th will be given a $0.69 dividend. The ex-dividend date is Friday, January 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.20%. IDEX's dividend payout ratio (DPR) is currently 42.72%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on IEX shares. DA Davidson decreased their target price on IDEX from $220.00 to $210.00 and set a "neutral" rating on the stock in a research report on Monday, August 5th. Argus cut shares of IDEX from a "buy" rating to a "hold" rating in a research report on Wednesday, August 14th. Robert W. Baird cut their target price on shares of IDEX from $245.00 to $241.00 and set an "outperform" rating on the stock in a research report on Thursday, October 31st. Oppenheimer lowered their price target on shares of IDEX from $245.00 to $238.00 and set an "outperform" rating for the company in a report on Monday, August 5th. Finally, Royal Bank of Canada raised their price objective on IDEX from $236.00 to $248.00 and gave the company an "outperform" rating in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $241.14.
Read Our Latest Stock Report on IEX
IDEX Profile
(
Free Report)
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.
Featured Articles
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.